We&Win Diversification Co Ltd (4113) - Cash Flow Conversion Efficiency
Based on the latest financial reports, We&Win Diversification Co Ltd (4113) has a cash flow conversion efficiency ratio of -0.061x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-258.80 Million ≈ $-8.15 Million USD) by net assets (NT$4.27 Billion ≈ $134.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 4113 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
We&Win Diversification Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how We&Win Diversification Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
We&Win Diversification Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of We&Win Diversification Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Indo Borax & Chemicals Limited
NSE:INDOBORAX
|
0.114x |
|
Chun Yu Works & Co Ltd
TW:2012
|
0.007x |
|
Loop Telecommunication International Inc
TW:3025
|
0.069x |
|
Equillium Inc
NASDAQ:EQ
|
-0.273x |
|
Binh Dien Fertilizer JSC
VN:BFC
|
0.226x |
|
China National Accord Medicines Corp Ltd
SHE:200028
|
-0.019x |
|
City Lodge Hotels Ltd
JSE:CLH
|
0.194x |
|
Stealth Group Holdings Ltd
AU:SGI
|
0.037x |
Annual Cash Flow Conversion Efficiency for We&Win Diversification Co Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of We&Win Diversification Co Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see market value of We&Win Diversification Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$4.27 Billion ≈ $134.43 Million |
NT$-2.92 Billion ≈ $-91.95 Million |
-0.684x | -239.56% |
| 2024-12-31 | NT$4.52 Billion ≈ $142.55 Million |
NT$2.22 Billion ≈ $69.87 Million |
0.490x | +262.79% |
| 2023-12-31 | NT$3.11 Billion ≈ $98.08 Million |
NT$-937.22 Million ≈ $-29.53 Million |
-0.301x | +34.45% |
| 2022-12-31 | NT$3.26 Billion ≈ $102.67 Million |
NT$-1.50 Billion ≈ $-47.16 Million |
-0.459x | -1233.09% |
| 2021-12-31 | NT$3.49 Billion ≈ $109.87 Million |
NT$141.35 Million ≈ $4.45 Million |
0.041x | +107.33% |
| 2020-12-31 | NT$3.42 Billion ≈ $107.65 Million |
NT$-1.89 Billion ≈ $-59.55 Million |
-0.553x | -473.46% |
| 2019-12-31 | NT$3.52 Billion ≈ $110.99 Million |
NT$521.83 Million ≈ $16.44 Million |
0.148x | +280.99% |
| 2018-12-31 | NT$3.73 Billion ≈ $117.54 Million |
NT$145.05 Million ≈ $4.57 Million |
0.039x | +135.02% |
| 2017-12-31 | NT$3.61 Billion ≈ $113.60 Million |
NT$-400.30 Million ≈ $-12.61 Million |
-0.111x | -- |
About We&Win Diversification Co Ltd
We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public facilities construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 20… Read more